Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation
Primary Purpose
Atrial Fibrillation, Catheter Ablation
Status
Completed
Phase
Phase 3
Locations
Spain
Study Type
Interventional
Intervention
Additional Complex Fractionated Electrograms ablation
Standard atrial fibrillation ablation procedure
Sponsored by
About this trial
This is an interventional treatment trial for Atrial Fibrillation focused on measuring Atrial fibrillation, Complex fractionated electrograms, CFAE
Eligibility Criteria
Inclusion Criteria:
- Patients with persistent (more than 7 days, or less than 7 days needing pharmacologic or electric cardioversion)
- Presence of atrial fibrillation at the beginning of the procedure
Exclusion Criteria:
- Hypo or hyperthyroidism
- Persistent long-lasting or non-defined duration atrial fibrillation
- Hypertrophic myocardiopathy
- Implantable defibrillation or pacemaker implanted
- Moderate or severe mitral valve disease or mitral prosthetic valve
- Ejection fraction less than 30%
- Left atrial anteroposterior diameter more than 50 mm.
- Previous atrial fibrillation ablation
- Contraindication to anticoagulation
- Left atrium thrombus
- Current infective disease or sepsis
- Pregnant women
- Current unstable angor
- Acute myocardial infarction in last 3 months
- Atrial fibrillation secondary to ionic disturbance, thyroids disease or secondary to any other reversible or non cardiovascular disease
- Reduced expectancy of life (less than 12 months)
- Patient participating in another clinical study that investigates a drug or device
- Psychologically unstable patient or denies to give informed consent
- Any cause that contraindicate ablation procedure or antiarrhythmic drug
Sites / Locations
- Hospital Clinic Universitari de Barcelona
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
ACVP plus roof line
Additional CFAEs ablation
Arm Description
Standard procedure for atrial fibrillation ablation, including pulmonary vein isolation plus roof line ablation. All ablation lines will be tested.
Atrial fibrillation ablation with pulmonary vein ablation and roof line. In addition, complex fractionated atrial electrograms ablation will be performed, lasting at most 30 minutes.
Outcomes
Primary Outcome Measures
Freedom from atrial arrhythmias without antiarrhythmic drugs
Secondary Outcome Measures
Freedom form atrial arrhythmias with or without antiarrhythmic drugs
Presence of any complications in the acute phase or during follow-up
Freedom from atypical atria flutter
Increase in radioscopy time and radiofrequency application time
Full Information
NCT ID
NCT00873067
First Posted
March 31, 2009
Last Updated
February 26, 2014
Sponsor
Hospital Clinic of Barcelona
Collaborators
Fundacio Clinic Barcelona
1. Study Identification
Unique Protocol Identification Number
NCT00873067
Brief Title
Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation
Official Title
Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation
Study Type
Interventional
2. Study Status
Record Verification Date
September 2011
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
February 2012 (Actual)
Study Completion Date
September 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Clinic of Barcelona
Collaborators
Fundacio Clinic Barcelona
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of this study is to evaluate whether performing complex fractionated atrial electrograms ablation improves outcomes in persistent or atrial fibrillation ablation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation, Catheter Ablation
Keywords
Atrial fibrillation, Complex fractionated electrograms, CFAE
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
142 (Actual)
8. Arms, Groups, and Interventions
Arm Title
ACVP plus roof line
Arm Type
Active Comparator
Arm Description
Standard procedure for atrial fibrillation ablation, including pulmonary vein isolation plus roof line ablation. All ablation lines will be tested.
Arm Title
Additional CFAEs ablation
Arm Type
Active Comparator
Arm Description
Atrial fibrillation ablation with pulmonary vein ablation and roof line. In addition, complex fractionated atrial electrograms ablation will be performed, lasting at most 30 minutes.
Intervention Type
Procedure
Intervention Name(s)
Additional Complex Fractionated Electrograms ablation
Other Intervention Name(s)
Complex atrial fractionated electrograms ablation
Intervention Description
Atrial fibrillation ablation with pulmonary vein ablation and roof line. In addition, complex fractionated atrial electrograms ablation will be performed, lasting at most 30 minutes.
Intervention Type
Procedure
Intervention Name(s)
Standard atrial fibrillation ablation procedure
Other Intervention Name(s)
ACVP ablation, Roof line
Intervention Description
Standard procedure for persistent atrial fibrillation including circumferential pulmonary vein ablation and roof line, both being tested. No other lines or lesions will be performed.
Primary Outcome Measure Information:
Title
Freedom from atrial arrhythmias without antiarrhythmic drugs
Time Frame
1-year follow-up
Secondary Outcome Measure Information:
Title
Freedom form atrial arrhythmias with or without antiarrhythmic drugs
Time Frame
1-year follow-up
Title
Presence of any complications in the acute phase or during follow-up
Time Frame
1-year follow-up
Title
Freedom from atypical atria flutter
Time Frame
1-year follow-up
Title
Increase in radioscopy time and radiofrequency application time
Time Frame
1-year follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with persistent (more than 7 days, or less than 7 days needing pharmacologic or electric cardioversion)
Presence of atrial fibrillation at the beginning of the procedure
Exclusion Criteria:
Hypo or hyperthyroidism
Persistent long-lasting or non-defined duration atrial fibrillation
Hypertrophic myocardiopathy
Implantable defibrillation or pacemaker implanted
Moderate or severe mitral valve disease or mitral prosthetic valve
Ejection fraction less than 30%
Left atrial anteroposterior diameter more than 50 mm.
Previous atrial fibrillation ablation
Contraindication to anticoagulation
Left atrium thrombus
Current infective disease or sepsis
Pregnant women
Current unstable angor
Acute myocardial infarction in last 3 months
Atrial fibrillation secondary to ionic disturbance, thyroids disease or secondary to any other reversible or non cardiovascular disease
Reduced expectancy of life (less than 12 months)
Patient participating in another clinical study that investigates a drug or device
Psychologically unstable patient or denies to give informed consent
Any cause that contraindicate ablation procedure or antiarrhythmic drug
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lluís Mont, MD
Organizational Affiliation
Hospital Clinic Universitary de Barcelona
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Elena Arbelo, MD, PhD
Organizational Affiliation
Hospital Clínic Universitari de Barcelona
Official's Role
Study Director
Facility Information:
Facility Name
Hospital Clinic Universitari de Barcelona
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Benefit of Complex Fractionated Atrial Electrograms Elimination in Atrial Fibrillation Ablation
We'll reach out to this number within 24 hrs